Seres Therapeutics, Inc. (MCRB)
Total Valuation
MCRB has a market cap or net worth of $117.42 million. The enterprise value is $195.21 million.
Market Cap | 117.42M |
Enterprise Value | 195.21M |
Important Dates
The last earnings date was Tuesday, March 5, 2024, before market open.
Earnings Date | Mar 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MCRB has 151.01 million shares outstanding. The number of shares has increased by 18.44% in one year.
Shares Outstanding | 151.01M |
Shares Change (YoY) | +18.44% |
Shares Change (QoQ) | +1.43% |
Owned by Insiders (%) | 5.68% |
Owned by Institutions (%) | 59.48% |
Float | 118.74M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.93 |
Forward PS | 115.12 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.55 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.78
Current Ratio | 1.78 |
Quick Ratio | 1.47 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.63 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -32.40% |
Return on Capital (ROIC) | -63.87% |
Revenue Per Employee | $542,167 |
Profits Per Employee | -$488,086 |
Employee Count | 233 |
Asset Turnover | 0.36 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.05% in the last 52 weeks. The beta is 2.27, so MCRB's price volatility has been higher than the market average.
Beta (1Y) | 2.27 |
52-Week Price Change | -86.05% |
50-Day Moving Average | 1.02 |
200-Day Moving Average | 2.30 |
Relative Strength Index (RSI) | 37.04 |
Average Volume (30 Days) | 4,678,065 |
Short Selling Information
The latest short interest is 18.40 million, so 12.18% of the outstanding shares have been sold short.
Short Interest | 18.40M |
Short Previous Month | 16.10M |
Short % of Shares Out | 12.18% |
Short % of Float | 15.49% |
Short Ratio (days to cover) | 3.79 |
Income Statement
In the last 12 months, MCRB had revenue of $126.33 million and -$113.72 million in losses. Loss per share was -$0.89.
Revenue | 126.33M |
Gross Profit | 126.33M |
Operating Income | -107.98M |
Pretax Income | -113.72M |
Net Income | -113.72M |
EBITDA | -85.43M |
EBIT | -100.55M |
Loss Per Share | -$0.89 |
Balance Sheet
The company has $136.15 million in cash and $213.94 million in debt, giving a net cash position of -$77.79 million or -$0.52 per share.
Cash & Cash Equivalents | 136.15M |
Total Debt | 213.94M |
Net Cash | -77.79M |
Net Cash Per Share | -$0.52 |
Equity / Book Value | -44.86M |
Book Value Per Share | -0.30 |
Working Capital | 76.75M |
Cash Flow
In the last 12 months, operating cash flow was -$117.35 million and capital expenditures -$7.98 million, giving a free cash flow of -$125.33 million.
Operating Cash Flow | -117.35M |
Capital Expenditures | -7.98M |
Free Cash Flow | -125.33M |
FCF Per Share | -$0.98 |
Margins
Gross margin is 100.00%, with operating and profit margins of -85.48% and -90.02%.
Gross Margin | 100.00% |
Operating Margin | -85.48% |
Pretax Margin | -90.02% |
Profit Margin | -90.02% |
EBITDA Margin | -67.63% |
EBIT Margin | -79.59% |
FCF Margin | -99.21% |
Dividends & Yields
MCRB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.44% |
Shareholder Yield | -18.44% |
Earnings Yield | -96.85% |
FCF Yield | -106.73% |
Analyst Forecast
The average price target for MCRB is $6.65, which is 759.06% higher than the current price. The consensus rating is "Hold".
Price Target | $6.65 |
Price Target Difference | 759.06% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | -6.83% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MCRB has an Altman Z-Score of -3.96 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.96 |
Piotroski F-Score | 1 |